Apyx Medical Corp (APYX) Form 8-K — Aug 7, 2026
Apyx Medical stockholders approved the company's 2026 Share Incentive Plan covering 4,000,000 shares of common stock at the annual meeting held August 6, 2026, with 16,186,776 votes in favor versus 2,755,882 against and 3,276,000 abstentions. All five incumbent directors were re-elected to serve until the 2027 annual meeting, though Baylor-Henry and Levine each drew roughly 6.65 million votes against. Stockholders also ratified RSM US LLP as independent auditor for the year ending December 31, 2026, and passed the non-binding say-on-pay resolution with about 21.5 million votes in favor.
Key figures
- Plan votes for
- 16186776
- Plan term years
- 10
- Broker non votes
- 7677267
- Directors elected
- 5
- Plan votes against
- 2755882
- Plan shares reserved
- 4000000
- Plan votes abstained
- 3276000
- Say on pay votes for
- 21458554
- Say on pay votes against
- 669298
- Auditor ratification votes for
- 29814618
- Auditor ratification votes against
- 31610
Price after filing
Close on the filing date to close N calendar days later (from $4.14). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.